Picture of Altamira Therapeutics logo

CYTOF — Altamira Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Auris Medical Announces Completion Of Bentrio Conformity Assessment Procedure For Marketing In EU

May 25 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES COMPLETION OF BENTRIO CONFORMITY
ASSESSMENT PROCEDURE FOR MARKETING IN EU
    * AURIS MEDICAL HOLDING LTD - MEETING ESSENTIAL REQUIREMENTS
FOR
MARKETING BENTRIO IN EUROPE UNDER CE MARK
    * AURIS MEDICAL HOLDING LTD - ON TRACK FOR FIRST PRODUCT
LAUNCH IN
EUROPE TOWARDS END OF Q2 2021

Source text for Eikon:  ID:nGNX65ySgR 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Altamira Therapeutics

See all news